In a report released on October 27, Roanna Ruiz from SVB Securities reiterated a Hold rating on Amarin (AMRN - Research Report), with a price target of $2.00. The company's shares closed last Friday at $1.23.Ruiz covers the Healthcare sector, focusing on stocks such as scPharmaceuticals, Amarin, and Myovant Sciences. According to TipRanks, Ruiz has an average return of -44.5% and a 17.78% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Amarin with a $2.50 average price target, representing a 103.25% upside. In a report released on October 28, H.C.
https://www.tipranks.com/news/blurbs/svb-securities-reaffirms-their-hold-rating-on-amarin-amrn?utm_source=advfn.com&utm_medium=referral